Skip to content

Clinical trials

Completed Graft vs Host Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graft vs Host Disease Status: Completed Clear all

347 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200011
20018
200215
200314
200420
200517
200613
200711
200820
200913
201015
201115
201212
201315
201416
201516
201614
201716
201818
20198
20208
20218
20223
20236

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed347

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)19
Dana-Farber Cancer Institute16
Fred Hutchinson Cancer Center16
M.D. Anderson Cancer Center12
H. Lee Moffitt Cancer Center and Research Institute11
National Cancer Institute (NCI)9
Novartis Pharmaceuticals8
University of Michigan Rogel Cancer Center7
Wyeth is now a wholly owned subsidiary of Pfizer7
Roswell Park Cancer Institute6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graft vs Host Disease347
Leukemia59
Myelodysplastic Syndromes59
Precursor Cell Lymphoblastic Leukemia-Lymphoma58
Leukemia, Myeloid, Acute54
Lymphoma, Non-Hodgkin44
Leukemia, Lymphocytic, Chronic, B-Cell43
Hodgkin Disease41
Hematologic Neoplasms39
Lymphoma39

Trials

Showing 26 to 50 of 347. Each trial links to its page on Pharma Observatory.

247 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.